A citation-based method for searching scientific literature

Kjell Bergfeldt, Bosse Rydh, Fredrik Granath, Henrik Grönberg, Lukman Thalib, Hans-Olov Adami, Per Hall. Lancet 2002
Times Cited: 46







List of co-cited articles
189 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
17

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
17

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
15

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
723
13

The nation-wide Swedish family-cancer database--updated structure and familial rates.
K Hemminki, X Li, K Plna, C Granström, P Vaittinen. Acta Oncol 2001
222
13


Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
13

Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.
Alexander Olawaiye, Lori Caesar, Debra Walsh, Mollie Lyman, John Yeh, Kerry Rodabaugh, David Marchetti, Shashikant Lele, Kunle Odunsi. Gynecol Oncol 2004
13
46

Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Aliki Tserkezoglou, Sofia Kontou, George Hadjieleftheriou, Nikiforos Apostolikas, Michalis Vassilomanolakis, Konstantinos Sikiotis, Emmanouel Salamalekis, Paraskevi Tseke, George Magiakos. Anticancer Res 2006
23
26

Ovarian malignancy in breast cancer patients with an adnexal mass.
Fiona Simpkins, Marianna Zahurak, Deborah Armstrong, Frances Grumbine, Robert Bristow. Obstet Gynecol 2005
20
30

Ovarian disease in women with breast cancer.
J P Curtin, R R Barakat, W J Hoskins. Obstet Gynecol 1994
58
10

Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation.
L E Hann, D M Lui, W Shi, A M Bach, D L Selland, M Castiel. Radiology 2000
37
13

Ovarian metastases from breast cancer: report of 29 cases.
Veronique Bigorie, Philippe Morice, Pierre Duvillard, Martine Antoine, Annie Cortez, Jean François Flejou, Serge Uzan, Emile Darai, Emmanuel Barranger. Cancer 2010
32
15

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997
697
8

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
876
8

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
8


Ovarian Metastases from Breast Cancer: A Series of 28 Cases.
Celine Pimentel, Margaux Becquet, Vincent Lavoue, Sebastien Henno, Jean Leveque, Lobna Ouldamer. Anticancer Res 2016
9
44


Cancer incidence in the first-degree relatives of ovarian cancer patients.
A Auranen, E Pukkala, J Mäkinen, R Sankila, S Grénman, T Salmi. Br J Cancer 1996
39
7

Familial breast and ovarian cancer: a Swedish population-based register study.
H Anderson, A Bladström, H Olsson, T R Möller. Am J Epidemiol 2000
50
6


Cancer risks in first-generation immigrants to Sweden.
Kari Hemminki, Xinjun Li, Kamila Czene. Int J Cancer 2002
138
6

Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
D E Goldgar, D F Easton, L A Cannon-Albright, M H Skolnick. J Natl Cancer Inst 1994
775
6

Contribution of BRCA1 mutations to ovarian cancer.
J F Stratton, S A Gayther, P Russell, J Dearden, M Gore, P Blake, D Easton, B A Ponder. N Engl J Med 1997
197
6

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
636
6

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Donald A Berry, Edwin S Iversen, Daniel F Gudbjartsson, Elaine H Hiller, Judy E Garber, Beth N Peshkin, Caryn Lerman, Patrice Watson, Henry T Lynch, Susan G Hilsenbeck,[...]. J Clin Oncol 2002
335
6

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Kelly Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo I Olopade, Andrea Eisen, Barbara Weber, Jane McLennan,[...]. J Clin Oncol 2004
424
6

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
483
6

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
719
6

Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
H A Risch, G R Howe. Cancer Epidemiol Biomarkers Prev 1995
111
6

Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
A Fishman, E Dekel, A Chetrit, L Lerner-Geva, A Bar-Am, D Beck, U Beller, G Ben-Baruch, B Piura, E Friedman,[...]. Gynecol Oncol 2000
18
16

Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.
S C Rubin, I Benjamin, K Behbakht, H Takahashi, M A Morgan, V A LiVolsi, A Berchuck, M G Muto, J E Garber, B L Weber,[...]. N Engl J Med 1996
343
6

Metastatic breast carcinoma to the abdomen and pelvis.
N R Abu-Rustum, C A Aghajanian, E S Venkatraman, F Feroz, R R Barakat. Gynecol Oncol 1997
24
12

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
J Boyd, Y Sonoda, M G Federici, F Bogomolniy, E Rhei, D L Maresco, P E Saigo, L A Almadrones, R R Barakat, C L Brown,[...]. JAMA 2000
384
6

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
6

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
512
6



Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
872
6

Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
Daisuke Nonaka, Luis Chiriboga, Robert A Soslow. Am J Surg Pathol 2008
171
6

Breast cancer metastatic to abdomen and pelvis: role of surgical resection.
Ram Eitan, Mary L Gemignani, Ennapadam S Venkatraman, Richard R Barakat, Nadeem R Abu-Rustum. Gynecol Oncol 2003
33
9

Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.
Carmen Tornos, Robert Soslow, Shirley Chen, Muzaffar Akram, Amanda J Hummer, Nadeen Abu-Rustum, Larry Norton, Lee K Tan. Am J Surg Pathol 2005
87
6


Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
Angela George, Stan Kaye, Susana Banerjee. Nat Rev Clin Oncol 2017
96
6

Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor.
S Guerriero, J L Alcazar, M A Pascual, S Ajossa, B Olartecoechea, L Hereter. Ultrasound Obstet Gynecol 2012
14
21


Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
6

Synchronous primary carcinoma of breast and ovary versus ovarian metastases.
Budhi S Yadav, S C Sharma, Tyler P Robin, Sharon Sams, Anothony D Elias, Virginia Kaklamani, P Kelly Marcom, Sara Schaefer, Gloria J Morris. Semin Oncol 2015
6
50

Breast cancer statistics, 2017, racial disparity in mortality by state.
Carol E DeSantis, Jiemin Ma, Ann Goding Sauer, Lisa A Newman, Ahmedin Jemal. CA Cancer J Clin 2017
866
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.